InflaRx N.V.

Research InflaRx N.V. (IFRX) on Bullrun: market cap USD 335.83M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerIFRX
• ExchangeNASDAQ
• CountryGermany
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 335.83M
• Financial periodQ1 2026
• RevenueUSD 29.33K
• Net income-USD 5.59M
• Free cash flow-USD 7.40M
• Gross margin0.0%

Valuation Snapshot

latest market cap is USD 335.83M.

About InflaRx N.V.

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator to treat variety of autoimmune and other inflammatory diseases.

Frequently asked questions

What is InflaRx N.V.'s market cap?

InflaRx N.V.'s market capitalization is USD 335.83M.

What does InflaRx N.V. do?

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator to treat variety of autoimmune and other inflammatory diseases.